The Parada lab uses genetically engineered mouse models to recapitulate and study human disease. These mouse strains are used to understand the natural history of tumors of the nervous system, including glioblastoma multiforme (GBM), malignant peripheral nerve sheath tumors (MPNST), neurofibromas, and other diseases associated with neurofibromatosis (NF1). We seek to develop mouse cancer models based on concrete hypotheses and to rapidly transfer findings for validation in human cancer samples.
Luis F. Parada, PhD
Director, Brain Tumor Center; Albert C. Foster Chair; American Cancer Society Research Professor
Professor
Research Focus
Developmental biologist Luis F. Parada uses genetically engineered mouse models to study neurofibromatosis, brain tumors, cancer stem cells, and tumor progression.Education
PhD, Massachusetts Institute of Technology- Office Phone: 646-888-2055 (Assistant to Dr. Parada)
- Lab Phone: 646-888-3780
Lab Members
Research Associate
Clinical Fellow
Graduate Student
Graduate Student
Research Scholar
Weill Cornell Graduate Student
Research Scholar
Research Assistant, Sr.
Hematology-oncology Fellows at MSKCC/Cornell
Research Fellow
Research Scholar
- Cell lineage-based stratification for glioblastoma. Wang Z, Sun D, Chen Y-J, Xie XP, Shi Y, Tabar V, Brennan CW, Bale TA, Jayewickrem, CD, Laks DR, Alcantara Llaguno S, and Parada LF., 2020, Cancer Cell, in Press.
- High resolution subventricular zone stem cell niche transcriptome reveals features of lineage, anatomy, and aging. Xie XP, Laks DR, Sun D, Poran A, Laughney AM, Wang Z, Sam J, Belenguer G, Fariñas I, Elemento O, Zhou X, Parada LF., 2020, Submitted.
- Member, National Academy of Science (2011)
- Fellow of American Association for the Advancement of Science (2009)
- Member, National Academy of Medicine- Former Institute of Medicine (2007)
- The Academy of Medicine, Engineering and Sciences of Texas (TAMEST) (2007)
- Member, American Academy of Arts and Sciences (2007)
Read more
- Member, Dana Alliance for Brain Initiatives (2003)
- Professor, American Cancer Society Research (2002)
